A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions
Open Access
- 1 September 2017
- journal article
- review article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 91 (1), 124-134
- https://doi.org/10.1002/ccd.27256
Abstract
Objectives To summarize the published data of combined transcatheter aortic and mitral valve intervention (CTAMVI). Background CTAMVI, a combination of either transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve‐in‐valve (TAViV) and transcatheter mitral valve replacement (TMVR), transcatheter mitral valve‐in‐valve/valve‐in‐ring (TMViV/ViR), or percutaneous mitral valve repair (PMVR) is an attractive alternative in high‐surgical risk patients with combined aortic and mitral valve disease. However, its procedural details and clinical outcomes have not been well described. Methods We performed a systematic review of all the published articles from PUBMED and EMBASE. Results A total of 37 studies with 60 patients were included. The indication for CTAMVI was high or inoperable surgical risk and symptomatic severe aortic stenosis (92%) or severe aortic regurgitation (8%) combined with moderate to severe/severe mitral stenosis (30%) or moderate/severe mitral regurgitation (65%) or both (5%). In majority of the cases, aortic valve intervention was performed prior to the mitral valve. Mortality rate were 25% for TAVR + TMVR (range 42 days to 10 months), 17% for TAVR + TMViV/ViR (range 13 days to 6 months), 0% for TAViV + TMViV/ViR (range 6–365 days), and 15% for TAVR/ViV + PMVR (range 17 days to 419 days). Significant (more than moderate) paravalvular regurgitation post‐procedure was rare. Conclusions CTAMVI appears to confer reasonable clinical outcome. Further large study is warranted to clarify the optimal strategy, procedural details and clinical outcomes in the future.Keywords
This publication has 63 references indexed in Scilit:
- 5-Year Experience With Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve DysfunctionJournal of the American College of Cardiology, 2013
- Concomitant Transcatheter Aortic and Mitral Valve-in-Valve Replacements Using Transfemoral Devices Via the Transapical Approach: First Case in United StatesJACC: Cardiovascular Interventions, 2013
- Successful dual-valve transcatheter therapy for severe aortic stenosis and mitral regurgitationInternational Journal of Cardiology, 2012
- Simultaneous Transcatheter Aortic and Mitral Valve-in-Valve Implantation in a Patient with Degenerated Bioprostheses and High Surgical RiskThe Thoracic and Cardiovascular Surgeon, 2011
- Percutaneous Double-Valve Interventions for Aortic Stenosis and Pure Mitral RegurgitationThe American Journal of Cardiology, 2011
- The First Report of Transcatheter Aortic Valve Implantation and Percutaneous Mitral Valve Repair in the Same PatientJACC: Cardiovascular Interventions, 2011
- Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patientCatheterization and Cardiovascular Interventions, 2011
- Percutaneous double valve interventionEuropean Heart Journal, 2010
- Outcomes of Patients Undergoing Concomitant Aortic and Mitral Valve Surgery in Northern New EnglandCirculation, 2009
- A Study of Functional Anatomy of Aortic-Mitral Valve Coupling Using 3D Matrix Transesophageal EchocardiographyCirculation: Cardiovascular Imaging, 2009